1. Home
  2. RYTM vs SHC Comparison

RYTM vs SHC Comparison

Compare RYTM & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • SHC
  • Stock Information
  • Founded
  • RYTM 2008
  • SHC 2015
  • Country
  • RYTM United States
  • SHC United States
  • Employees
  • RYTM N/A
  • SHC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • SHC Medical Specialities
  • Sector
  • RYTM Health Care
  • SHC Health Care
  • Exchange
  • RYTM Nasdaq
  • SHC Nasdaq
  • Market Cap
  • RYTM 3.8B
  • SHC 3.3B
  • IPO Year
  • RYTM 2017
  • SHC 2020
  • Fundamental
  • Price
  • RYTM $57.38
  • SHC $13.13
  • Analyst Decision
  • RYTM Strong Buy
  • SHC Strong Buy
  • Analyst Count
  • RYTM 12
  • SHC 5
  • Target Price
  • RYTM $75.42
  • SHC $15.80
  • AVG Volume (30 Days)
  • RYTM 671.0K
  • SHC 1.2M
  • Earning Date
  • RYTM 05-07-2025
  • SHC 05-01-2025
  • Dividend Yield
  • RYTM N/A
  • SHC N/A
  • EPS Growth
  • RYTM N/A
  • SHC N/A
  • EPS
  • RYTM N/A
  • SHC 0.09
  • Revenue
  • RYTM $136,863,000.00
  • SHC $1,106,788,000.00
  • Revenue This Year
  • RYTM $43.84
  • SHC $3.87
  • Revenue Next Year
  • RYTM $65.62
  • SHC $5.77
  • P/E Ratio
  • RYTM N/A
  • SHC $150.64
  • Revenue Growth
  • RYTM 48.88
  • SHC 2.78
  • 52 Week Low
  • RYTM $35.17
  • SHC $9.53
  • 52 Week High
  • RYTM $68.58
  • SHC $17.08
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 43.00
  • SHC 69.44
  • Support Level
  • RYTM $62.69
  • SHC $10.68
  • Resistance Level
  • RYTM $65.53
  • SHC $13.37
  • Average True Range (ATR)
  • RYTM 3.04
  • SHC 0.46
  • MACD
  • RYTM -0.73
  • SHC 0.27
  • Stochastic Oscillator
  • RYTM 1.14
  • SHC 92.15

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Share on Social Networks: